A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Mannkind Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,648,327 shares of MNKD stock, worth $18.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,648,327
Previous 1,647,727 60.73%
Holding current value
$18.2 Million
Previous $8.6 Million 93.36%
% of portfolio
0.04%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $5.01 Million - $6.7 Million
1,000,600 Added 60.73%
2,648,327 $16.6 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $1.3 Million - $1.74 Million
320,100 Added 24.11%
1,647,727 $8.6 Million
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $794,625 - $1.29 Million
244,500 Added 22.57%
1,327,627 $6.01 Million
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $1.79 Million - $2.3 Million
-536,500 Reduced 33.12%
1,083,127 $3.94 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $323,357 - $450,715
82,700 Added 5.38%
1,619,627 $6.69 Million
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $1.9 Million - $2.45 Million
-511,500 Reduced 24.97%
1,536,927 $6.26 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $7.18 Million - $10.2 Million
1,817,400 Added 786.66%
2,048,427 $8.4 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $697,701 - $1.24 Million
231,027 New
231,027 $1.22 Million
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $35,057 - $62,630
13,130 New
13,130 $50,000
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $50,828 - $86,330
-19,400 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $1.18 Million - $1.57 Million
-291,647 Reduced 93.76%
19,400 $85,000
Q3 2021

Nov 15, 2021

SELL
$3.89 - $5.48 $4.28 Million - $6.03 Million
-1,101,001 Reduced 77.97%
311,047 $1.35 Million
Q2 2021

Aug 16, 2021

SELL
$3.61 - $5.45 $5.34 Million - $8.06 Million
-1,478,400 Reduced 51.15%
1,412,048 $7.7 Million
Q1 2021

May 17, 2021

BUY
$3.14 - $6.14 $4.5 Million - $8.81 Million
1,434,200 Added 98.49%
2,890,448 $11.3 Million
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $1.09 Million - $2.47 Million
611,300 Added 72.35%
1,456,248 $4.56 Million
Q3 2020

Nov 16, 2020

BUY
$1.56 - $2.08 $1.13 Million - $1.5 Million
721,778 Added 586.0%
844,948 $1.59 Million
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $115,779 - $272,205
123,170 New
123,170 $216,000
Q3 2019

Nov 14, 2019

SELL
$1.04 - $1.44 $240,344 - $332,784
-231,100 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$1.09 - $1.88 $15,696 - $27,072
-14,400 Reduced 5.87%
231,100 $266,000
Q1 2019

May 15, 2019

BUY
$1.14 - $2.25 $1,937 - $3,825
1,700 Added 0.7%
245,500 $484,000
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $26,214 - $52,684
-25,700 Reduced 9.54%
243,800 $258,000
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $32,623 - $70,737
-32,300 Reduced 10.7%
269,500 $493,000
Q2 2018

Aug 14, 2018

BUY
$1.59 - $2.38 $33,390 - $49,980
21,000 Added 7.48%
301,800 $573,000
Q1 2018

May 15, 2018

BUY
$2.28 - $3.8 $251,711 - $419,520
110,400 Added 64.79%
280,800 $640,000
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $355,679 - $1.05 Million
156,000 Added 1083.33%
170,400 $395,000
Q3 2017

Nov 14, 2017

BUY
$1.15 - $2.29 $16,560 - $32,976
14,400
14,400 $31,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.77B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.